
AstraZeneca’s AI lung cancer screening program executes 5 mn tests, flags 50k individuals at high risk
New Delhi: UK pharma major AstraZeneca in partnership with health-tech company Qure.ai, announced the completion of 5 million artificial intelligence (AI) enabled chest X-rays (CXRs) across more than 20 countries in Asia, the Middle East, Africa, and Latin …